SMLR Valuation

Semler Scientific Inc

Add to Watchlist

Advanced Chart

29.640

-0.99(-3.232%)1D

Overview
Forecast
Valuation
Earnings

SMLR Relative Valuation

SMLR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SMLR is overvalued; if below, it's undervalued.

Historical Valuation

Semler Scientific Inc (SMLR) is now in the Overvalued zone, suggesting that its current forward PS ratio of 14.03 is considered Overvalued compared with the five-year average of 24.30. The fair price of Semler Scientific Inc (SMLR) is between 7.02 to 20.93 according to relative valuation methord. Compared to the current price of 29.51 USD , Semler Scientific Inc is Overvalued By 40.97%.

Relative Value

Fair Zone

7.02-20.93

Current Price：29.51

40.97%

Overvalued

-98.80

Trailing

Forward

-38.32

EV/EBITDA

Semler Scientific Inc. (SMLR) has a current EV/EBITDA of -38.32. The 5-year average EV/EBITDA is 15.81. The thresholds are as follows: Strongly Undervalued below -13.74, Undervalued between -13.74 and 1.04, Fairly Valued between 30.59 and 1.04, Overvalued between 30.59 and 45.37, and Strongly Overvalued above 45.37. The current Forward EV/EBITDA of -38.32 falls within the Strongly Undervalued range.

-121.55

EV/EBIT

Semler Scientific Inc. (SMLR) has a current EV/EBIT of -121.55. The 5-year average EV/EBIT is 11.72. The thresholds are as follows: Strongly Undervalued below -58.76, Undervalued between -58.76 and -23.52, Fairly Valued between 46.95 and -23.52, Overvalued between 46.95 and 82.19, and Strongly Overvalued above 82.19. The current Forward EV/EBIT of -121.55 falls within the Strongly Undervalued range.

14.06

Semler Scientific Inc. (SMLR) has a current PS of 14.06. The 5-year average PS is 6.91. The thresholds are as follows: Strongly Undervalued below -1.37, Undervalued between -1.37 and 2.77, Fairly Valued between 11.04 and 2.77, Overvalued between 11.04 and 15.18, and Strongly Overvalued above 15.18. The current Forward PS of 14.06 falls within the Overvalued range.

-125.51

P/OCF

Semler Scientific Inc. (SMLR) has a current P/OCF of -125.51. The 5-year average P/OCF is 5.60. The thresholds are as follows: Strongly Undervalued below -56.24, Undervalued between -56.24 and -25.32, Fairly Valued between 36.52 and -25.32, Overvalued between 36.52 and 67.44, and Strongly Overvalued above 67.44. The current Forward P/OCF of -125.51 falls within the Strongly Undervalued range.

-453.47

P/FCF

Semler Scientific Inc. (SMLR) has a current P/FCF of -453.47. The 5-year average P/FCF is -3.34. The thresholds are as follows: Strongly Undervalued below -186.75, Undervalued between -186.75 and -95.04, Fairly Valued between 88.36 and -95.04, Overvalued between 88.36 and 180.06, and Strongly Overvalued above 180.06. The current Forward P/FCF of -453.47 falls within the Strongly Undervalued range.

Semler Scientific Inc (SMLR) has a current Price-to-Book (P/B) ratio of 1.09. Compared to its 3-year average P/B ratio of 3.13 , the current P/B ratio is approximately -65.09% higher. Relative to its 5-year average P/B ratio of 8.21, the current P/B ratio is about -86.67% higher. Semler Scientific Inc (SMLR) has a Forward Free Cash Flow (FCF) yield of approximately 2.69%. Compared to its 3-year average FCF yield of 7.76%, the current FCF yield is approximately -65.32% lower. Relative to its 5-year average FCF yield of 5.95% , the current FCF yield is about -54.72% lower.

1.06

P/B

Median3y

3.13

Median5y

8.21

2.69

FCF Yield

Median3y

7.76

Median5y

5.95

Competitors Valuation Multiple

The average P/S ratio for SMLR's competitors is 4.89, providing a benchmark for relative valuation. Semler Scientific Inc Corp (SMLR) exhibits a P/S ratio of 14.03, which is 187.05% above the industry average. Given its robust revenue growth of -43.19%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

SMLR.O

Semler Scientific Inc

Standard BioTools Inc

Treace Medical Concepts Inc

Performance Decomposition

Market capitalization of SMLR increased by 11.01% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 0.08 to 814.57.

The secondary factor is the Revenue Growth, contributed -43.19%to the performance.

Overall, the performance of SMLR in the past 1 year is driven by Margin Expansion. Which is more sustainable.

-43.19%

14.47M → 8.22M

Revenue Growth

1018112.50%

0.08 → 814.57

Margin Expansion

-1018058.30%

0.00 → 7.52

P/E Change

11.01%